Oops! Page Not Found
Unfortunately the page you're looking doesn't exist (anymore) or there was an error in the link you followed or typed. This way to the home page.
Sitemap
Blog
- 01/25/2024 - CCR8 Targeting: A Promising Strategy for Cancer Immunotherapy and Beyond
- 09/19/2023 - Unlocking the Potential of SYnAbs Monoclonal Antibodies Against MMP-9
- 06/15/2023 - LO-MM SYnAbs rat-anti IgM mouse monoclonals
- 04/24/2023 - Enhancing CRP Protein Detection with Monoclonal Antibodies: A Breakthrough in Inflammatory Disease Diagnostics
- 04/01/2023 - Unravel the Epigenetic Code: Unlocking the Secrets of Histone Modifications with SYnAbs Specific Monoclonal Antibodies
- 02/11/2023 - Decoding Matrix Metalloproteinases (MMP): A Journey towards effective Therapeutic interventions
- 01/25/2023 - Claudin and Occludin : potential of tetraspan transmembrane proteins of cell-cell tight junctions as antibody therapeutic targets
- 11/25/2022 - SYnAbs is awarded a major Horizon European grant for the generation of therapeutic antibodies on transmembrane targets and highly conserved soluble proteins
- 10/22/2022 - Membrane Antibody Therapeutic Approach to Ion Channelopathies
- 10/03/2022 - SYnAbs launches unique anti-glucagon monoclonals
- 09/20/2022 - SYnAbs signs a research agreement with Domain Therapeutics to discover therapeutic antibodies on GPCRs
- 08/13/2022 - G protein-coupled endothelin receptors and their natural and therapeutic ligands
- 07/12/2022 - Glutamate transporter : a brief history of excitatory amino acid transmembrane proteins
- 06/09/2022 - TACA, promising oncology targets?
- 04/30/2022 - Therapeutic trends of G protein-coupled receptor drugs as Antibody Drug Conjugates candidates
- 04/05/2022 - CX3CR1, GPCR CX3C chemokine receptor 1 (CX3CR1): transmembrane receptor of therapeutic interest?
- 03/19/2022 - Immuno-Oncology Therapeutic Potential of Adenosine Receptors: Targeting the Purinergic Pathway
- 03/05/2022 - MARK & MARL SYnAbs mouse anti-rat light chain monoclonals
- 02/26/2022 - LO-MG SYnAbs rat-anti IgG mouse monoclonals
- 02/06/2022 - The therapeutic challenges of receptor tyrosine kinases
- 01/21/2022 - The enigmatic subclass antibody, SYngular products from SYnAbs
- 01/13/2022 - SYnAbs innovative monoclonal antibodies targeting hemoglobinopathia diseases
- 12/04/2021 - CD2, the missed opportunity for monoclonal antibody therapy?
- 10/30/2021 - The end of animal use for antibody generation in Europe. Really ?
- 10/02/2021 - Anti-CD25 therapeutic monoclonal antibody strategies
- 09/11/2021 - C3a and C5a anaphylatoxin receptors, therapeutic GPCR targets of the complement system
- 08/30/2021 - Therapeutic targets of the complement system
- 08/21/2021 - Monoclonal antibodies to human CD cell surface antigens
- 08/14/2021 - Orphan GPCR and their untapped therapeutic potential: the next wave of antibody drug targets?
- 06/30/2021 - CC chemokine receptors: latest news on Beta chemokine receptor therapeutics
- 06/10/2021 - Chemokine receptors: a promising GPCR family to target?
- 04/09/2021 - Functional antibodies: B-cell depleting antibodies
- 03/19/2021 - SYnAbs and Belgian Volition ink strategic agreement on epigenetics
- 03/08/2021 - Viral Envelope Proteins, targets for Therapeutic Neutralizing Antibodies (NAbs)
- 02/20/2021 - Anti-drug antibody generation : How to effectively monitor your therapeutic drug
- 01/25/2021 - How do ion channels work?
- 01/11/2021 - A brief history of the discovery of ion channels
- 12/14/2020 - How does GPCR move? Learn the dynamics of the seven-(pass)-transmembrane domain receptors
- 11/28/2020 - Bald & Bearded : the DHT effect
- 11/14/2020 - Immunoaffinity chromatography : Principles and Tools of the market
- 11/06/2020 - Polyclonals & Oligoclonals: Alternatives to Monoclonals?
- 10/26/2020 - IL-1β monoclonal antibodies
- 10/24/2020 - Surrogate Antibodies & Therapeutic Monoclonals: Humans Mimicking Animals
- 10/17/2020 - Glycan & anti-glycan : the rise of glycobiology
- 10/06/2020 - TRAIL, the new Grail?
- 10/06/2020 - HEK293: when the virus meets the cell
- 10/05/2020 - History of GPCR and GPCR antibodies
- 10/01/2020 - Unique anti-valproic acid monoclonals
- 09/28/2020 - KIAA1199, Hybid or CEMIP? The same protein for a diversity of biological functions
- 09/23/2020 - Keeping Up with the SERPins
- 08/10/2020 - Microbiome: Zero to One
- 08/03/2020 - CHO cell line. A 60-year-old story.
- 07/17/2020 - Cancer & Bacteria, a long story rising from the ashes
- 07/01/2020 - IL1RAP, a new biomarker of interest for cancer targeting
- 06/26/2020 - An introduction to the Exosome world
- 06/23/2020 - Revealing the full potential of Adeno Associated Virus thanks to molecular biology
- 06/09/2020 - How much do you know about COVID-19 proteins?
- 05/25/2020 - Patients’ Immune Battle Against COVID-19
- 05/05/2020 - Latest News on COVID-19
- 04/03/2020 - Immune Response to Coronavirus infection
- 03/31/2020 - 11 Strategies To Treat Coronavirus You Should Know
- 03/17/2020 - Bispecific Antibody: The Janus God Of Therapeutics?
- 02/25/2020 - The Future Of Therapeutic Antibodies Development
- 02/19/2020 - More human than human is our motto
- 02/14/2020 - "Anta", "Block", "Neutra"...but Who Are They?
- 02/10/2020 - In Gut We Trust
- 02/04/2020 - Not One Monoclonal But Two mAbs can detect ANY PROTEIN!
- 01/30/2020 - The Dark Side Of CAR-T Therapy
- 01/16/2020 - In accordance with FDA, can a biotinylated mAb be replaced by a DNP marked mAb?
- 12/05/2019 - LO-HG4 Anti-human IgG4 monoclonal antibody
- 11/25/2019 - Hybridoma VS Display : The Fight Of The Century
- 11/14/2019 - Mycotoxins: the reign of terror
- 10/18/2019 - Are you sure you know everything about the Rat?
- 09/25/2019 - Three Letters You Should Be Aware Of
- 09/18/2019 - Most frequently asked questions on secondary antibodies
- 09/16/2019 - Your DNA isn't your destiny: news on epigenetics
- 07/02/2019 - mAbexperts commits to the future of immunotherapy: Complete VHH-CAR-T design
- 06/26/2019 - Best tips to select an outsourcing provider for custom antibody generation
- 06/10/2019 - Innovative anti-VHH antibodies : SYnAbs enters the nano-world
- 04/27/2019 - The CAM family: a new target for monitoring or treating cancers?
- 04/20/2019 - SYnAbs and Univercells announce success on anti-biosimilar antibody assay
- 04/16/2019 - Why DNA immunization is still necessary?
- 04/12/2019 - Replacing in-vivo by an in-vitro test? Rabies mAb example
- 03/11/2019 - Neurogenic and SYnAbs deal for schizophrenia detection
- 01/28/2019 - Horiba & SYnAbs partnership : Production of monoclonal antibody directed against a steroid hormone and its binding study thanks to SPRi technology
- 12/14/2017 - SYnAbs/RD Biotech unique expertise in CAR-T cells
- 08/03/2016 - The small molecule detection challenge : the aflatoxin case study